TipRanks
Biosyent Inc (TSE:RX)
:RX
Canadian Market
Want to see TSE:RX full AI Analyst Report?

Biosyent (RX) Revenue

55 Followers

Biosyent Revenue

Biosyent had a revenue of 19.87M in the quarter ending Jun 30, 2026, with 42.89%. This bring the company's revenue in the last twelve months to 55.67M, Decreased 21.08%. In the fiscal year ending Dec 31, 2025, Biosyent had annual revenue of 43.05M with 22.90% growth.
Revenue (ttm)
55.67M
Revenue Growth
40.91%
P/S Ratio
4.22
Revenue/Employee
C$717,533
Employees
60
Market Cap
C$181.85M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
43.05M8.02M+22.90%
Dec 31, 2024
35.03M3.44M+10.89%
Dec 31, 2023
31.59M3.67M+13.12%
Dec 31, 2022
27.93M-693.03K-2.42%
Dec 31, 2021
28.62M6.29M+28.15%
Dec 31, 2020
22.33M907.84K+4.24%
Dec 31, 2019
21.42M-102.70K-0.48%
Dec 31, 2018
21.53M764.27K+3.68%
Dec 31, 2017
20.76M